Related Experiment Videos
Activity criteria in systemic lupus erythematosus
S Bombardieri1, C Vitali, L Caponi
1Clinical Immunology Unit, Istituto di Patologia Medica dell'Università di Pisa, Italy.
Clinical and Experimental Rheumatology
|November 1, 1994
Summary
A new European Consensus Lupus Activity Measurement (ECLAM) index effectively measures systemic lupus erythematosus (SLE) disease activity. ECLAM proved superior for classifying SLE patients, whether assessing current status or changes over time.
Area of Science:
- Rheumatology
- Clinical Immunology
- Systemic Lupus Erythematosus Research
Background:
- Systemic lupus erythematosus (SLE) is characterized by fluctuating disease activity.
- Existing clinical indices for measuring SLE activity have limitations.
- A need exists for a reliable and validated index to assess SLE disease activity.
Purpose of the Study:
- To reach a European consensus on the definition of SLE activity.
- To develop and validate a new clinical index for SLE activity measurement.
- To compare the performance of the new index against existing lupus activity indices.
Main Methods:
- A 5-year European multicenter study.
- Development and validation of the European Consensus Lupus Activity Measurement (ECLAM) index.
- Comparative analysis of ECLAM with other commonly used lupus activity indices.
Main Results:
- The European Consensus Lupus Activity Measurement (ECLAM) index was successfully created and validated.
- ECLAM demonstrated superior performance in classifying SLE patients.
- ECLAM proved effective as both a single state and a transition index for SLE activity.
Conclusions:
- The ECLAM index is a reliable tool for assessing SLE disease activity.
- ECLAM offers advantages over existing indices for patient classification.
- This validated index can aid in managing SLE flares and remissions.